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doi:10.1016/j.ejvs.2009.01.015Abstract Objectives: Endothelial dysfunction is a known precursor of atherosclerosis and can
be assessed by measuring the brachial artery flow-mediated dilatation (FMD) via ultrasonog-
raphy. This study investigated endothelial function in young type 1 diabetics without cardio-
vascular morbidity or diabetes-related pathology.
Methods: Young diabetics and healthy controls were recruited, both meeting strict inclusion
and exclusion criteria. To prove absence of subclinical atherosclerosis, intima-media thickness
(IMT) measurements at the carotid bifurcation were done in all of them. FMD was measured at
the brachial artery. The results were compared using the t-test and the influences of different
variables on FMD were assessed using multiple linear regression.
Results: Twenty-six diabetics (23.4 5.8 years) and 36 healthy volunteers (23.1 2.8 years)
were recruited. The duration of diabetes was 9.2 5.3 years; metabolic control was moderate
(HbA1c 7.6 1.0%) and IMT was normal in both groups.
FMD was significantly impaired in type 1 diabetics (7.13 0.43 vs. 8.77 0.43%; pZ 0.002).
The FMD grade was associated with diabetes and age. Patients with a good metabolic control
(HbA1c 7.0%) had a better FMD.
Conclusions: In type 1 diabetics, even without preclinical or clinical atherosclerosis, endothe-
lial function is already disturbed and can be detected using ultrasonography.
ª 2009 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.821 43 60; fax: þ32 3 821 43 96.
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Table 1a Exclusion criteria for all tested individuals
Obesity (Body mass index> 25 kg m2)
Smoking
Arterial hypertension
Age <18 years or >35 years
Any underlying disease, other than diabetes
Use of any medication
Proven clinical atherosclerosis
Family history positive for cardiovascular disease
HDL and LDL are high- and low-density lipoproteins, respectively.
612 R. Hurks et al.Atherosclerosis is a chronic progressive vascular degenera-
tion, which manifests itself mainly in coronary, carotid and
peripheral arteries.1 An accurate and reproducible method
to detect (sub)clinical atherosclerosis is to measure the
intima-media thickness (IMT) at the common carotid artery,
using ultrasound.2,3 The IMT has a predictive value for
development of cardiovascular morbidity and mortality.4
Endothelial dysfunction is considered to precede
atherosclerosis and is mainly characterised by impaired
vasomotor function, which results in a decreased vasodi-
latation.5 Nitric oxide (NO) is essential for the regulation of
the vascular tonus. NO is formed from L-arginin by endo-
thelial-derived NO synthase (eNOS) in reaction to mechan-
ical, pharmacological and biochemical stimuli.5 Diminished
NO release and eNOS expression form the fundament of
endothelial dysfunction and are present in atheroscle-
rosis.5,6 A noninvasive technique to determine endothelial
function involves measuring flow-mediated dilatation (FMD)
via ultrasound.7 The FMD is defined as the reactive
vasodilatation of the brachial artery after hyperaemia and
is considered to be a physiological reaction of the artery.
Decreased FMD has been demonstrated in patients with risk
factors for atherosclerosis, such as diabetic children and
adolescents.8e10 Endothelial dysfunction, defined as
a decreased FMD, has a predictive value for future cardio-
vascular disease.11 Diabetes is an important risk factor for
atherosclerosis, and both the incidence and mortality of
cardiovascular disease are increased in diabetic patients.12
Preclinical evaluation of atherosclerosis and early
intervention are essential for reducing cardiovascular
morbidity and mortality. Presence of endothelial dysfunc-
tion before development of preclinical atherosclerosis
(defined as an increased IMT) has not been demonstrated
before. This is relevant for future therapeutic intervention
strategies.
In the present study, we investigated endothelial func-
tion in young adults with type 1 diabetes mellitus (T1DM)
without preclinical or clinical atherosclerosis. T1DM had to
be the only risk factor for atherosclerosis, and patients with
diabetes-related co-morbidities were excluded.Table 1b Additional exclusion criteria for diabetics
LDL e cholesterol> 4 mmol l1
HDL e cholesterol< 0.9 mmol l1 (male), <1.1 mmol l1
(female)
Triglycerides> 2.8 mmol l1
HbA1c> 10%
Micro-albuminuria> 20 mg min1
Neuropathy
Retinopathy
Use of any medication,
other than insulin
HbA1c is glycosylated haemoglobin.Materials and Methods
Type 1 diabetics, aged 16e36 years, regularly attending the
diabetes outpatient clinic of the Antwerp University Hospital
were consecutively recruited. To minimise influences other
than T1DM on endothelial function, strict exclusion criteria
were met (Tables 1a and b). The FMD tests and IMT
measurements were performed, together with the annual
screening for diabetes-related co-morbidities. A control
group of non-diabetics was recruited among medical
students; they met exclusion criteria as well (Table 1a).
The conducted tests were standardised. All measure-
ments were performed by the same technician with an
extensive experience (>2300 measurements) in a neutral
environment with a constant temperature to minimise the
influence of stress. A strict preparation was conducted by
each test subject to avoid factors that might influence
vascular tone: no caffeine or alcohol use, no intensive
physical activity 24 h before the testing and no food intake
6 h prior to the testing.9,13,14 All tests were preceded bymeasuring the blood pressure. Coefficients of variance
(measured at six consecutive days at the same time) were
1% and 7% for the basal diameter and FMD, respectively.
Carotid IMT was evaluated in the supine position, with
the head turned 45 away from the side being scanned. The
reference point for measurement was the beginning of the
dilatation of the carotid bulb. The two-dimensional B-mode
image of the posterior wall of the right common carotid
artery was gained 1e2 cm proximal to the carotid bifurca-
tion. The radio-frequency signals originating from an M-line
perpendicular to the longitudinal and transversal axes of
the artery, R-wave triggered, were analysed thrice using
three different interrogation angles: 0 from midline,
30e60 from midline (anterior oblique) and 90e100 from
midline (lateral). The mean IMT of the three measurements
was calculated. This method has been validated and is
reproducible.15
The FMD was evaluated by ultrasonography of the right
brachial artery at rest (baseline arterial diameter) and
during reactive hyperaemia after inflating and deflating
a forearm blood pressure cuff (200 mmHg or at least
50 mmHg above peak systolic blood pressure for 4 min).
Continuous electrocardiogram (ECG) registration was used
to measure the correct end-diastolic diameter, coincident
with the R-wave. Post-occlusion measurements were taken
every 30 s over the following 4 min. To calculate the
maximal vasodilatation compared with baseline (peak FMD
percentage), the mean of the three measurements at
baseline and the maximal post-occlusion value were used.
Ultrasound studies were performed using the AU5
Ultrasound system (Esaote, Biomedica, Genova, Italy),
equipped with a 10-MHz linear-array transducer. Data
analysis was performed using the Wall-Tracker System
(WTS, P-Medical, Maastricht, the Netherlands).
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mean standard deviation (SD). The outcomes, IMT and
FMD, are expressed as mean standard error (SE). The
differences between groups were tested using a Student’s
t-test; for non-Gaussian data, the ManneWhitney U-test
was used. Multiple linear regression was applied to identify
the relationship among the various parameters. An inter-
action variable (T1DM*gender) was entered to analyse the
interaction between those two variables. R2 is used to
identify the proportion of the variability of the dependent
variable explained by the regression model. Values of the
coefficient B and the p-values are provided. Two-tailed p-
values 0.05 are considered statistically significant.
Data are analysed using the statistical package SPSS
Version 15.0 (SPSS Inc, Chicago, IL, USA). For this cross-
sectional study, we calculated that 23 patients per group
would be required.
Results
With regards to clinical characteristics (Table 2), the
healthy control (CO) and diabetic groups (T1DM) did not
differ significantly in age, gender distribution and blood
pressure at the moment of testing. Body mass index (BMI)
was higher in T1DM but was within the normal range
(22.1 2.0 vs. 21.1 1.7 kg m2, pZ 0.020).
Carotid IMT (0.482 0.011 in T1DM vs. 0.499 0.011 mm
in CO, pZ 0.275) was not significantly different in diabetics
and was not affected by gender. The influence of different
variables on the dependent variable IMT was analysed usingTable 2 General clinical and metabolic characteristics of
the study objects
Characteristic Diabetes Healthy
controls
p-value
n 26 36
Age (years) 23.4 5.8 23.1 2.8 0.581
Gender
(male/female)
12/14 16/20 0.895
Body mass index
(kg m2)
22.1 2.0 21.1 1.7 0.020
Blood pressure e
systolic (mmHg)
127 24 121 16 0.322
Blood pressure e
diastolic (mmHg)
70 14 67 8 0.602
Duration of diabetes
(years)
9.2 5.3
HbA1c (%) 7.6 1.0
Total cholesterol
(mmol l1)
4.3 0.6
LDL (mmol l1) 2.2 0.5
HDL (mmol l1) 1.6 0.4
Tryglycerides
(mmol l1)
1.0 0.4
Total cholesterol/HDL
ratio
2.7 0.6
Values are expressed as mean SD.
HDL and LDL are high- and low-density lipoproteins, respec-
tively. HbA1c is glycosylated haemoglobin.multiple linear regression, but no significant model could
be fitted.
Endothelial function as assessed by the brachial artery FMD
was significantly impaired in T1DM compared to CO
(7.13 0.43 vs. 8.77 0.43%; pZ 0.002 powerZ 85.2%).
Split for gender, FMD remained significantly lower inmale and
female T1DM patients compared to CO (6.72 0.76 vs.
8.95 0.49% formale patients (pZ 0.024) and7.48 0.46 vs.
8.66 0.50% for female patients (pZ 0.036), respectively).
No statistically significant differences were found for gender
within T1DM or CO. Multiple linear regression in the entire
study group for the dependent variable FMD (R2Z 0.355;
p< 0.001) resulted in a model with T1DM (BZ 2.393;
p< 0.001), age (BZ 0.197; pZ 0.004) and BMI (BZ 0.256;
pZ 0.096). An interaction term for gender and T1DM was
entered in the model to further analyse the influence of both
the variables oneachother. This turnedout tobenegativeand
was therefore excluded from the final model.
T1DM split for good (HbA1c 7.0%) and moderate/bad
(HbA1c> 7.0%) metabolic controls resulted in no differ-
ences in gender, age, duration of diabetes, BMI, IMT, blood
pressure, total cholesterol, low-density lipoprotein (LDL),
high-density lipoprotein (HDL) and triglycerides.
The FMD was significant better in the group with good
metabolic control compared to poor metabolic control
(8.71 0.84 vs. 6.55 0.44%, pZ 0.047; powerZ 62.6%).
Multiple linear regression (stepwise backward) in T1DM for
the dependent variable HbA1c (R2Z 0.500; pZ 0.042)
resulted in a model with significant associations with age
(BZ0.071; pZ 0.042), HDL (BZ0.245; pZ 0.006) and
total cholesterol (BZ 0.095; pZ 0.006).Discussion
In this study, we describe endothelial dysfunction in
young type 1 diabetes patients with good-to-moderate
metabolic control (HbA1c7, 6 1, 1%), without (pre)clin-
ical atherosclerosis and without other risk factors hereon.
We compare these patients with healthy controls
matched by our strict inclusion criteria as mentioned in
Tables 1a and b.
Although BMI differs between both the groups, both
values are considerably under the set cut-off point of
25 kgm2, and BMI did not turn out to be significant in the
multiple linear regression analysis. We therefore conclude
that this difference will not influence the outcome. To
investigate the effect of gender on FMD, both the inde-
pendent variable FMD and gender itself were entered as an
interaction term (gender)T1DM) in the model. This showed
no direct or indirect effect of gender on FMD.
The IMT measurements are accurate and reproduc-
ible,2,3,15 and we minimised variability by performing
measurements in three angles 12 times in total. The IMT
was not significantly different between T1DM and CO. None
of the individuals had elevated IMT values,16 thus allowing
us to conclude that the endothelial function can be prop-
erly assessed in this study without impacting the effects of
atherosclerosis.
Previous studies of endothelial function to compare
T1DM and CO showed significant differences in IMT in both
high (42 years) and low (11 years) age groups.17, 18 It has to
614 R. Hurks et al.be noted that inclusion criteria were less strict (smokers
were not excluded) and the metabolic control was worse
(HbA1cZ 8.9 1.4%) compared to our study, respectively.
We expect our comparable IMT measurements to result
from our strict inclusion criteria.
Age is a known risk factor for atherosclerosis; increasing
IMT with age has been documented in several
studies.2,3,16,19 In the present study, no association was
found between age and IMT or FMD and IMT, probably
because of the narrow age distribution and the cross-
sectional study design. A study in patients with athero-
sclerosis (aged 61 2 years) did show an association
between IMT and FMD.20 Another group found an associa-
tion between IMT and duration of disease,21 which could
not be confirmed by either us or others.22 This might be due
to a selection bias owing to their specific criteria, mainly
including patients with prolonged duration of diabetes and
without clinical atherosclerosis.
In our study, type 1 diabetics have a significantly lower
FMD (pZ 0.002; powerZ 85.2%). Split for gender, the
difference remains lower for T1DM between males
(pZ 0.024) and females (pZ 0.036). No differences in
FMD were found when males were compared with
females. Remarkable results are described in literature. In
a study with older T1DM and CO (41.5 13.2 and
42.2 13.4 years, respectively), increased disease dura-
tion (21 10 years), worse metabolic control
(HbA1cZ 8.0 1.1%) and specific risk factors, but without
clinical atherosclerosis, no difference in FMD was found.23
This study was limited by the relatively small groups (17
vs. 17) and the lack of power calculations. Another group
did not find a difference in FMD in a younger age group
(13.5 3.5 years), a short duration of disease (<5 years)
and a bad metabolic control (HbA1cZ 9.4 2.1%).24
Other researchers found a significantly lower FMD in T1DM
compared to CO.8,20,21 These studies differ from the
present one by significantly different IMT between both
the groups and elevated IMT values in two of the
studies.20,21 In the present study, we found associations
between FMD and both T1DM (pZ 0.001) and age
(pZ 0.006) in all the studied subjects. The positive weak
coefficient for age (BZ 0.192) was unexpected, but our
population was characterised by a narrow age distribution
(23.2 4.3 years) and the study design was cross-
sectional; therefore, these findings cannot be extrapo-
lated to other age categories. To further explore the
reasons for the positive association for age in T1DM, we
found a negative association between age and HbA1c
(rZ0.071; pZ 0.042), so older patients had a better
metabolic control in our study.
The mean HbA1c (7.6 1.0%) represents moderate
metabolic control, but is considerably better compared to
previously mentioned studies.18,23,24 The endothelial func-
tion (FMD) turned out to be better in patients with good
metabolic control compared to moderate/bad control
(pZ 0.047); no other differences between both the groups
were found, suggesting a positive influence of good meta-
bolic control on endothelial function. FMD was not associ-
ated with HbA1c.
Brazilian researchers found that FMD and HbA1c were
positively associated in a young group of patients
(13.4 3.3 years) with a short duration of diabetes(2.9 1.2 years) and a bad metabolic control
(HbA1cZ 9.35 2.1%).24 They hypothesised, based upon
animal experiments, that chronic hyperglycaemia would
modify eNOS as an early adaptive mechanism of the
endothelium. Their results are not being confirmed by us or
others.18,23 The same group found no association between
FMD and duration of disease.24 Another study with a rela-
tively small number of patients (nZ 17) did not find this
association in older patients (41.5 13.2 years) with pro-
longed disease duration (21.5 10.2 years) or in patients
with atherosclerotic risk factors.23 A recent study found
a negative association between FMD and disease duration,
FMD being already impaired in the first 10 years of
disease.11 Their study population was older (46.6 9.7
years), had a prolonged duration of diabetes (16.2 9.3
years), increased IMT (0.644 0.033 mm) and atheroscle-
rotic risk factors. Remarkably, these authors deny any
influence of increasing BMI, percentage smokers and
HbA1c on FMD with increasing duration of disease.11
Comparable to these results, others report decreased FMD
during the first 10 years of disease in a population with
increased IMT.8 In a study on young diabetics (15.0 2.4
years) without IMT alterations, a decreasing FMD with
disease duration was found.18 We have no explanation for
the lack of this association in our patient group, but to
draw conclusions from associations like this, a longitudinal
study design is needed.
Lipids were associated with HbA1c, and not with IMT or
FMD; since the obtained values were within the normal
range, their influence is considered not substantial.
In conclusion, the results of this study demonstrate
endothelial dysfunction in type 1 diabetics without
atherosclerotic risk factors, without clinical or preclinical
atherosclerosis (increased IMT). The present study differs
from previously conducted studies by lack of a difference in
IMT in patients vs. controls.
Endothelial function is better in T1DM with a good meta-
bolic control (HbA1c 7.0%) compared to moderate/bad
metabolic control (HbA1c> 7%), suggesting a positive influ-
ence on endothelial function of well-regulated diabetics.
A longitudinal study is needed to analyse the evolution
of atherosclerotic risk factors, ageing and increasing dura-
tion of diabetes and their influence on endothelial function
within both the T1DM and CO groups to further explore this
entity and to seek for novel therapeutic targets.
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